Literature DB >> 21488942

SREBP-2: a link between insulin resistance, hepatic cholesterol, and inflammation in NASH.

Derrick M Van Rooyen, Geoff C Farrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21488942     DOI： 10.1111/j.1440-1746.2011.06704.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  17 in total

Review 1.  Dyslipidaemia of diabetes and the intestine.

Authors:  Gerald H Tomkin; Daphne Owens
Journal:  World J Diabetes       Date:  2015-07-10

2.  Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.

Authors:  Christopher M Depner; Moises Torres-Gonzalez; Sasmita Tripathy; Ginger Milne; Donald B Jump
Journal:  J Nutr       Date:  2012-06-27       Impact factor: 4.798

3.  Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6.

Authors:  Rongya Tao; Xiwen Xiong; Ronald A DePinho; Chu-Xia Deng; X Charlie Dong
Journal:  J Lipid Res       Date:  2013-07-23       Impact factor: 5.922

4.  The incretin enhancer, sitagliptin, exacerbates expression of hepatic inflammatory markers in rats fed a high-cholesterol diet.

Authors:  Rashmi Pathak; Avinash Kumar; Henry A Palfrey; Laura A Forney; Kirsten P Stone; Narayan R Raju; Thomas W Gettys; Subramanyam N Murthy
Journal:  Inflamm Res       Date:  2019-05-09       Impact factor: 4.575

5.  Genetic ablation of Cyp8b1 preserves host metabolic function by repressing steatohepatitis and altering gut microbiota composition.

Authors:  Jay V Patankar; Chi K Wong; Vijay Morampudi; William T Gibson; Bruce Vallance; George N Ioannou; Michael R Hayden
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-10-24       Impact factor: 4.310

6.  Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.

Authors:  Anuradha Rao; Astrid Kosters; Jamie E Mells; Wujuan Zhang; Kenneth D R Setchell; Angelica M Amanso; Grace M Wynn; Tianlei Xu; Brad T Keller; Hong Yin; Sophia Banton; Dean P Jones; Hao Wu; Paul A Dawson; Saul J Karpen
Journal:  Sci Transl Med       Date:  2016-09-21       Impact factor: 17.956

7.  Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansion and improves dyslipidemia in vivo.

Authors:  Salil Varshney; Kripa Shankar; Muheeb Beg; Vishal M Balaramnavar; Sunil Kumar Mishra; Pankaj Jagdale; Shishir Srivastava; Yashpal S Chhonker; Vijai Lakshmi; Bhushan P Chaudhari; Rabi Shankar Bhatta; Anil Kumar Saxena; Anil Nilkanth Gaikwad
Journal:  J Lipid Res       Date:  2014-03-19       Impact factor: 5.922

8.  The combination of atorvastatin with silymarin enhances hypolipidemic, antioxidant and anti-inflammatory effects in a rat model of metabolic syndrome.

Authors:  I Marková; H Malínská; M Hüttl; D Miklánková; O Oliyarnyk; M Poruba; Z Rácová; L Kazdová; R Večeřa
Journal:  Physiol Res       Date:  2021-01-14       Impact factor: 1.881

9.  Cyclodextrin protects podocytes in diabetic kidney disease.

Authors:  Sandra Merscher-Gomez; Johanna Guzman; Christopher E Pedigo; Markku Lehto; Robier Aguillon-Prada; Armando Mendez; Mariann I Lassenius; Carol Forsblom; Taehyun Yoo; Rodrigo Villarreal; Dony Maiguel; Kevin Johnson; Ronald Goldberg; Viji Nair; Ann Randolph; Matthias Kretzler; Robert G Nelson; George W Burke; Per-Henrik Groop; Alessia Fornoni
Journal:  Diabetes       Date:  2013-07-08       Impact factor: 9.461

10.  Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.

Authors:  Jing-Hui Sun; Xu Liu; Li-Xin Cong; He Li; Cheng-Yi Zhang; Jian-Guang Chen; Chun-Mei Wang
Journal:  Lipids Health Dis       Date:  2017-08-01       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.